ELAN News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

EL

Mkt Cap

$11.77B

Volume

4.30M

Next Earnings

November 6th

Chart Financials Earnings News About Insider Filings

Elanco Director Purchases 40,000 Shares for $936,000Lawrence Erik Kurzius, Director at Elanco Animal Health, purchased 40,000 shares at $23.40 per share on August 20, 2026, expanding his direct holdings by 27%. The insider purchase signals confidence in the company, with analysts showing strong bullish sentiment—89% of 18 analysts rate it a buy with a median 12-month price target of $32, representing potential 31% upside.The Motley Fool · Sep 4, 2026

Veterinary API Manufacturing Market to Reach USD 18.48 Billion by 2035 as Animal Health Investments and Zoonotic Disease Prevention Accelerate – SNS InsiderThe global Veterinary API Manufacturing Market is projected to grow from USD 7.21 billion in 2025 to USD 18.48 billion by 2035, driven by rising zoonotic disease prevention efforts, increasing pet ownership, and expanding animal healthcare investments. The market is segmented by service type, synthesis type, therapeutic category, and animal type, with North America and Asia-Pacific leading regional growth.GlobeNewswire Inc. · Jun 18, 2026

Elanco Animal Health Moves Higher On Earnings Strength And Product MomentumElanco Animal Health (NYSE: ELAN) shares rose 9.33% following better-than-expected Q1 earnings of 40 cents per share (vs. 35 cents consensus) and $1.37 billion in sales (vs. $1.29 billion consensus). The company raised full-year guidance and reported strong growth across both Pet Health and Farm Animal segments, driven by new product launches and market expansion. Emergency use authorization approvals for Negasunt Powder and Tanidil also supported the stock movement.Benzinga · May 6, 2026

PRISM MarketView Launches PetCare IndexPRISM MarketView launched the PRISM PetCare Index to track publicly traded companies driving growth in the global pet care sector, projected to exceed $350 billion. The index includes companies advancing veterinary services, pet pharmaceuticals, insurance, diagnostics, and premium nutrition. Key companies highlighted include Elanco Animal Health, Chewy, and Trupanion, which are positioned to benefit from increasing consumer spending on pet healthcare, preventative services, and subscription-based offerings.GlobeNewswire Inc. · Feb 12, 2026

Should You Buy Zoetis Before Feb. 12?Zoetis is set to report Q4 2025 earnings on Feb. 12 after disappointing guidance last quarter caused an 11% stock decline. While the company has beaten earnings in four consecutive quarters and lowered expectations could set up positive surprises, investors remain concerned about persistent macro headwinds affecting its livestock business and osteoarthritis treatments. The analyst recommends long-term investors wait until after earnings to enter a position, as further downside risk exists if guidance disappoints again.The Motley Fool · Feb 9, 2026

The Glucosamine Supplements for Dogs Market, Global Forecast 2026-2032 | Innovation Drives Canine Glucosamine Supplement Market with New Chewable and Liquid FormatsThe global canine glucosamine supplement market is experiencing rapid growth, expanding from USD 236.44 million in 2025 to USD 257.55 million in 2026, with a projected CAGR of 7.27% through 2032, reaching USD 386.54 million. Market growth is driven by increased pet ownership, higher consumer spending on veterinary wellness, product innovation in formats like chewables and liquids, and omnichannel distribution strategies. Key opportunities include palatability improvements, multi-ingredient formulations, and age-specific product targeting.GlobeNewswire Inc. · Jan 19, 2026

Canine Vaccines Market Size to Reach USD 3.45 Billion by 2033, Supported by Rising Pet Ownership and Preventive Animal Healthcare Focus – SNS InsiderThe global canine vaccines market is projected to grow from USD 2.05 billion in 2025 to USD 3.45 billion by 2033, with a CAGR of 6.79%. Growth is driven by rising pet ownership, increased awareness of preventive animal healthcare, and higher veterinary spending. Core vaccines and rabies vaccines lead by market share, while combination vaccines and Lyme disease vaccines show the fastest growth. North America dominates with 36.5% market share, while Asia Pacific is expected to grow fastest at 8.22% CAGR.GlobeNewswire Inc. · Jan 16, 2026

Diesel Generator Market is expected to generate a revenue of USD 27.42 Billion by 2032, Globally, at 5.28% CAGR: Verified Market Research®The global diesel generator market is projected to grow at a CAGR of 5.28% from 2026 to 2032, reaching USD 27.42 billion by 2032 from USD 18.17 billion in 2024. Growth is driven by industrialization, infrastructure development, rising power outages, and data center expansion. However, the market faces headwinds from stringent environmental regulations, high operational costs, and the shift toward renewable energy solutions.GlobeNewswire Inc. · Jan 9, 2026

VIRBAC: Hyperthyroïdie féline : Virbac acquiert ThyronormVirbac has acquired a specialized liquid medication for feline hyperthyroidism from Norbrook for around £100 million. The product, currently generating €14 million in revenue, will be distributed under the Thyronorm and Felanorm brands across multiple markets.GlobeNewswire Inc. · Dec 16, 2025

VIRBAC: Feline Hyperthyroidism: Virbac acquires ThyronormVirbac has acquired an innovative drug from Norbrook to treat feline hyperthyroidism, valued at £100 million. The product will be distributed under Thyronorm and Felanorm brands across multiple countries, targeting a growing market of senior cats with this common endocrine disease.GlobeNewswire Inc. · Dec 16, 2025

EL

ELANElanco Animal Health Incorporated Common Stock

ELAN

Pay with—

Available Balance0.00

Your PositionYou don't own any ELAN yet.

Related Tickers

Earnings